- Home
- RVP vs LGVN Comparison
RVP vs LGVN Comparison
Compare RVP & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- LGVN
- Stock Information
- Founded
- RVP 1994
- LGVN 2014
- Country
- RVP United States
- LGVN United States
- Employees
- RVP N/A
- LGVN N/A
- Industry
- RVP Medical/Dental Instruments
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- RVP Health Care
- LGVN Health Care
- Exchange
- RVP Nasdaq
- LGVN Nasdaq
- Market Cap
- RVP 20.5M
- LGVN 23.4M
- IPO Year
- RVP 2001
- LGVN 2021
- Fundamental
- Price
- RVP $0.72
- LGVN $1.42
- Analyst Decision
- RVP
- LGVN Strong Buy
- Analyst Count
- RVP 0
- LGVN 3
- Target Price
- RVP N/A
- LGVN $8.67
- AVG Volume (30 Days)
- RVP 41.4K
- LGVN 127.0K
- Earning Date
- RVP 05-15-2025
- LGVN 05-08-2025
- Dividend Yield
- RVP N/A
- LGVN N/A
- EPS Growth
- RVP N/A
- LGVN N/A
- EPS
- RVP N/A
- LGVN N/A
- Revenue
- RVP $33,745,343.00
- LGVN $2,225,000.00
- Revenue This Year
- RVP N/A
- LGVN $1.30
- Revenue Next Year
- RVP N/A
- LGVN $19.15
- P/E Ratio
- RVP N/A
- LGVN N/A
- Revenue Growth
- RVP N/A
- LGVN 127.50
- 52 Week Low
- RVP $0.56
- LGVN $0.77
- 52 Week High
- RVP $1.22
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- RVP 43.22
- LGVN 45.45
- Support Level
- RVP $0.70
- LGVN $1.30
- Resistance Level
- RVP $0.80
- LGVN $1.52
- Average True Range (ATR)
- RVP 0.04
- LGVN 0.11
- MACD
- RVP -0.00
- LGVN -0.01
- Stochastic Oscillator
- RVP 20.00
- LGVN 25.53
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.